>AT3G05630.1 | PLDP2 phospholipase D
MSTDKLLLPNGVKSDGVIRMTRADAAAAAASSSLGGGSQIFDELPKAAIVSVSRPDTTDF
SPLLLSYTLELQYKQFKWTLQKKASQVLYLHFALKKRLIIEELHDKQEQVREWLHSLGIF
DMQGSVVQDDEEPDDGALPLHYTEDSIKNRNVPSRAALPIIRPTIGRSETVVDRGRTAMQ
GYLSLFLGNLDIVNSKEVCKFLEVSRLSFAREYGSKMKEGYVTVKHLRDVPGSDGVRCCL
PTHCLGFFGTSWTKVWAVLKPGFLALLEDPFSGKLLDIMVFDTLGLQGTKESSEQPRLAE
QVKEHNPLRFGFKVTSGDRTVRLRTTSSRKVKEWVKAVDEAGCYSPHRFGSFAPPRGLTS
DGSQAQWFVDGHTAFEAIAFAIQNATSEIFMTGWWLCPELYLKRPFEDHPSLRLDALLET
KAKQGVKIYILLYKEVQIALKINSLYSKKRLQNIHKNVKVLRYPDHLSSGIYLWSHHEKI
VIVDYQVCFIGGLDLCFGRYDTAEHKIGDCPPYIWPGKDYYNPRESEPNSWEETMKDELD
RRKYPRMPWHDVHCALWGPPCRDVARHFVQRWNHSKRNKAPNEQTIPLLMPHHHMVLPHY
LGTREIDIIAAAKPEEDPDKPVVLARHDSFSSASPPQEIPLLLPQETDADFAGRGDLKLD
SGARQDPGETSEESDLDEAVNDWWWQIGKQSDCRCQIIRSVSQWSAGTSQPEDSIHRAYC
SLIQNAEHFIYIENQFFISGLEKEDTILNRVLEALYRRILKAHEENKCFRVVIVIPLLPG
FQGGIDDFGAATVRALMHWQYRTISREGTSILDNLNALLGPKTQDYISFYGLRSYGRLFE
DGPIATSQIYVHSKLMIVDDRIAVIGSSNINDRSLLGSRDSEIGVVIEDKEFVESSMNGM
KWMAGKFSYSLRCSLWSEHLGLHAGEIQKIEDPIKDATYKDLWMATAKKNTDIYNQVFSC
IPNEHIRSRAALRHNMALCKDKLGHTTIDLGIAPERLESCGSDSWEILKETRGNLVCFPL
QFMCDQEDLRPGFNESEFYTAPQVFH*
>AT2G26830.1 | emb1187 (embryo defective 1187) kinase/ phosphotransferase alcohol group as acceptor
MGAAKNIWALANAEDAANDAEQIPYSSFVVDTSLPLPLMIPRIIELCKDLFKNWGELDDS
LFSVERVSGGITNLLLKVSVKEDTNKEVSVTVRLYGPNTEYVINREREILAIKYLSAAGF
GAKLLGGFGNGMVQSFINARTLEPSDMREPKIAAQIARELGKFHKVDIPGSKEPQLWVDI
LKFYEKASTLTFEEPDKQKLFETISFEELHKEIIELREFTGLLNAPVVFAHNDLLSGNFM
LNDEEEKLYLIDFEYGSYNYRGFDIGNHFNEYAGYDCDYSLYPSKEEQYHFIKHYLQPDK
PDEVSIAEVESVFVETDAYKLASHLYWAIWAIIQARMSPIEFEYLGYFFLRYNEYKKQKP
LTFSLVTSHLSASL*
>AT1G07790.1 | HTB1 DNA binding
MAPRAEKKPAEKKTAAERPVEENKAAEKAPAEKKPKAGKKLPPKEAGDKKKKRSKKNVET
YKIYIFKVLKQVHPDIGISSKAMGIMNSFINDIFEKLAQESSKLARYNKKPTITSREIQT
AVRLVLPGELAKHAVSEGTKAVTKFTSS*
>AT1G43560.1 | Aty2 (Arabidopsis thioredoxin y2) electron carrier/ protein disulfide oxidoreductase
MAISLATAYISPCFTPESSNSASPSRTLSSVRLPSQIRRFGSVQSPSSSTRFAPLTVRAA
KKQTFNSFDDLLQNSDKPVLVDFYATWCGPCQLMVPILNEVSETLKDIIAVVKIDTEKYP
SLANKYQIEALPTFILFKDGKLWDRFEGALPANQLVERIENSLQVKQ*
>AT4G03520.1 | ATHM2 enzyme activator
MAAFTCTSRPPISLRSETRIVSSSPSASSLSSRRMFAVLPESSGLRIRLSLSPASLTSIH
QPRVSRLRRAVVCEAQETTTDIQVVNDSTWDSLVLKATGPVVVDFWAPWCGPCKMIDPLV
NDLAQHYTGKIKFYKLNTDESPNTPGQYGVRSIPTIMIFVGGEKKDTIIGAVPKTTLTSS
LDKFLP*
>AT4G03520.1 | ATHM2 enzyme activator
MAAFTCTSRPPISLRSETRIVSSSPSASSLSSRRMFAVLPESSGLRIRLSLSPASLTSIH
QPRVSRLRRAVVCEAQETTTDIQVVNDSTWDSLVLKATGPVVVDFWAPWCGPCKMIDPLV
NDLAQHYTGKIKFYKLNTDESPNTPGQYGVRSIPTIMIFVGGEKKDTIIGAVPKTTLTSS
LDKFLP*
>AT4G03520.2 | ATHM2 enzyme activator
MIDPLVNDLAQHYTGKIKFYKLNTDESPNTPGQYGVRSIPTIMIFVGGEKKDTIIGAVPK
TTLTSSLDKFLP*
>AT4G03520.2 | ATHM2 enzyme activator
MIDPLVNDLAQHYTGKIKFYKLNTDESPNTPGQYGVRSIPTIMIFVGGEKKDTIIGAVPK
TTLTSSLDKFLP*
>AT1G80070.1 | SUS2 (ABNORMAL SUSPENSOR 2)
MWNNNDGMPLAPPGTGGSMMPPPPAAHPSYTALPPPSNPTPPVEPTPEEAEAKLEEKARK
WMQLNSKRYGDKRKFGFVETQKEDMPPEHVRKIIRLVFFSSFSTISKYSLLDNYFLARDH
GDMSSKKFRHDKRVYLGALKFVPHAVFKLLENMPMPWEQVRDVKVLYHITGAITFVNEIP
WVVEPIYMAQWGTMWIMMRREKRDRRHFKRMRFPPFDDEEPPLDYADNLLDVDPLEPIQL
ELDEEEDSAVHTWFYDHKPLVKTKLINGPSYRRWNLSLPIMATLHRLAGQLLSDLIDRNY
FYLFDMPSFFTAKALNMCIPGGPKFEPLYRDMEKGDEDWNEFNDINKLIIRSPLRTEYRI
AFPHLYNNRPRKVKLCVYHSPMIMYIKTEDPDLPAFYYDPLIHPISNTNKEKRERKVYDD
EDDFALPEGVEPLLRDTQLYTDTTAAGISLLFAPRPFNMRSGRTRRAEDIPLVSEWFKEH
CPPAYPVKVRVSYQKLLKCYVLNELHHRPPKAQKKKHLFRSLAATKFFQSTELDWVEVGL
QVCRQGYNMLNLLIHRKNLNYLHLDYNFNLKPVKTLTTKERKKSRFGNAFHLCREILRLT
KLVVDANVQFRLGNVDAFQLADGLQYIFSHVGQLTGMYRYKYRLMRQIRMCKDLKHLIYY
RFNTGPVGKGPGCGFWAPMWRVWLFFLRGIVPLLERWLGNLLARQFEGRHSKGVAKTVTK
QRVESHFDLELRAAVMHDVLDAMPEGIKQNKARTILQHLSEAWRCWKANIPWKVPGLPVP
IENMILRYVKSKADWWTNVAHYNRERIRRGATVDKTVCRKNLGRLTRLWLKAEQERQHNY
LKDGPYVTPEEALAIYTTTVHWLESRKFSPIPFPPLSYKHDTKLLILALERLKESYSVAV
RLNQQQREELGLIEQAYDNPHEALSRIKRHLLTQRGFKEVGIEFMDLYSYLIPVYEIEPL
EKITDAYLDQYLWYEGDKRHLFPNWIKPADSEPPPLLVYKWCQGINNLQGIWDTGDGQCV
VMLQTKFEKFFEKIDLTMLNRLLRLVLDHNIADYVSAKNNVVLSYKDMSHTNSYGLIRGL
QFASFVVQFYGLLLDLLLLGLTRASEIAGPPQMPNEFMTFWDTKVETRHPIRLYSRYIDK
VHIMFKFTHEEARDLIQRYLTEHPDPNNENMVGYNNKKCWPRDARMRLMKHDVNLGRSVF
WDMKNRLPRSITTLEWENGFVSVYSKDNPNLLFSMCGFEVRILPKIRMTQEAFSNTKDGV
WNLQNEQTKERTAVAFLRVDDEHMKVFENRVRQILMSSGSTTFTKIVNKWNTALIGLMTY
FREATVHTQELLDLLVKCENKIQTRIKIGLNSKMPSRFPPVIFYTPKEIGGLGMLSMGHI
LIPQSDLRYSKQTDVGVTHFRSGMSHEEDQLIPNLYRYIQPWESEFIDSQRVWAEYALKR
QEAQAQNRRLTLEDLEDSWDRGIPRINTLFQKDRHTLAYDKGWRVRTDFKQYQVLKQNPF
WWTHQRHDGKLWNLNNYRTDVIQALGGVEGILEHTLFKGTYFPTWEGLFWEKASGFEESM
KYKKLTNAQRSGLNQIPNRRFTLWWSPTINRANVYVGFQVQLDLTGIFMHGKIPTLKISL
IQIFRAHLWQKIHESVVMDLCQVLDQELDALEIETVQKETIHPRKSYKMNSSCADVLLFA
AHKWPMSKPSLVAESKDMFDQKASNKYWIDVQLRWGDYDSHDIERYTRAKFMDYTTDNMS
IYPSPTGVMIGLDLAYNLHSAFGNWFPGSKPLLAQAMNKIMKSNPALYVLRERIRKGLQL
YSSEPTEPYLSSQNYGEIFSNQIIWFVDDTNVYRVTIHKTFEGNLTTKPINGAIFIFNPR
TGQLFLKVIHTSVWAGQKRLGQLAKWKTAEEVAALVRSLPVEEQPKQIIVTRKGMLDPLE
VHLLDFPNIVIKGSELQLPFQACLKIEKFGDLILKATEPQMVLFNIYDDWLKSISSYTAF
SRLILILRALHVNNEKAKMLLKPDKSVVTEPHHIWPSLTDDQWMKVEVALRDLILSDYAK
KNNVNTSALTQSEIRDIILGAEITPPSQQRQQIAEIEKQAKEASQLTAVTTRTTNVHGDE
LIVTTTSPYEQSAFGSKTDWRVRAISATNLYLRVNHIYVNSDDIKETGYTYIMPKNILKK
FICVADLRTQIAGYLYGISPPDNPQVKEIRCVVMVPQWGNHQLVHLPSSLPEHDFLNDLE
PLGWLHTQPNELPQLSPQDVTSHSRILENNKQWDGEKCIILTCSFTPGSCSLTSYKLTQT
GYEWGRLNKDNGSNPHGYLPTHYEKVQMLLSDRFLGFYMVPESGPWNYSFTGVKHTLSMK
YSVKLGSPKEFYHEEHRPTHFLEFSNMEEADITEGDREDTFT*
>AT1G19650.1 | SEC14 cytosolic factor putative / phosphoglyceride transfer protein putative
MSGPLDRFTSPCFSNNGEKREKKSDFEVSEDEKKTRIGGILKKKSSKSKFRHSLKRRGSR
SIDRTLSLTFEDIHDAEELRYVSEFRQSLISDHLLPPNLDDYHIMLRFLFARKFDLGKAK
LMWTNMIQWRRDFGTDTILEDFEFPELDEVLRYYPQGYHGVDKEGRPVYIERLGKVDASK
LMQVTTLERYLRYHVKEFEKTITVKFPACCIAAKRHIDSSTTILDVQGLGLKNFTKTARD
LIIQLQKIDSDNYPETLHRMFIINAGSGFKLLWGTVKSFLDPKTVSKIHVLGNKYQNKLL
EMIDASQLPDFFGGTCTCADQGGCMRSDKGPWKDSEILKMGRSGGTFCRHAGAFLSSDSQ
ISSSDKPTYSLKVSDTSTAKSGSELEEMASPKTNTNNHVPKLTPVSEYANGNISPTVLSE
YEECVPMVDKVVDVAWQLQEMPNASEGPQYTSSLGKIGSVRHIWSWLTAFFISFFTLLAS
LALPQTKEHSQLHSSSVRAELCDERIARESRPPSPPRSTITERVIISSVLSRLGDLEKQI
ENLHSRKSEMPHEKEELLNAAVYRVDALEAELITTKKALHEALIRQEELLGYIDRQKEAK
CRRKKFCW*
>AT1G19650.1 | SEC14 cytosolic factor putative / phosphoglyceride transfer protein putative
MSGPLDRFTSPCFSNNGEKREKKSDFEVSEDEKKTRIGGILKKKSSKSKFRHSLKRRGSR
SIDRTLSLTFEDIHDAEELRYVSEFRQSLISDHLLPPNLDDYHIMLRFLFARKFDLGKAK
LMWTNMIQWRRDFGTDTILEDFEFPELDEVLRYYPQGYHGVDKEGRPVYIERLGKVDASK
LMQVTTLERYLRYHVKEFEKTITVKFPACCIAAKRHIDSSTTILDVQGLGLKNFTKTARD
LIIQLQKIDSDNYPETLHRMFIINAGSGFKLLWGTVKSFLDPKTVSKIHVLGNKYQNKLL
EMIDASQLPDFFGGTCTCADQGGCMRSDKGPWKDSEILKMGRSGGTFCRHAGAFLSSDSQ
ISSSDKPTYSLKVSDTSTAKSGSELEEMASPKTNTNNHVPKLTPVSEYANGNISPTVLSE
YEECVPMVDKVVDVAWQLQEMPNASEGPQYTSSLGKIGSVRHIWSWLTAFFISFFTLLAS
LALPQTKEHSQLHSSSVRAELCDERIARESRPPSPPRSTITERVIISSVLSRLGDLEKQI
ENLHSRKSEMPHEKEELLNAAVYRVDALEAELITTKKALHEALIRQEELLGYIDRQKEAK
CRRKKFCW*
>AT1G19650.2 | SEC14 cytosolic factor putative / phosphoglyceride transfer protein putative
MFWRSFICFITCSSIIRYEVEREHCLFHDFSSLCRFLFARKFDLGKAKLMWTNMIQWRRD
FGTDTILEDFEFPELDEVLRYYPQGYHGVDKEGRPVYIERLGKVDASKLMQVTTLERYLR
YHVKEFEKTITVKFPACCIAAKRHIDSSTTILDVQGLGLKNFTKTARDLIIQLQKIDSDN
YPETLHRMFIINAGSGFKLLWGTVKSFLDPKTVSKIHVLGNKYQNKLLEMIDASQLPDFF
GGTCTCADQGGCMRSDKGPWKDSEILKMGRSGGTFCRHAGAFLSSDSQISSSDKPTYSLK
VSDTSTAKSGSELEEMASPKTNTNNHVPKLTPVSEYANGNISPTVLSEYEECVPMVDKVV
DVAWQLQEMPNASEGPQYTSSLGKIGSVRHIWSWLTAFFISFFTLLASLALPQTKEHSQL
HSSSVRAELCDERIARESRPPSPPRSTITERVIISSVLSRLGDLEKQIENLHSRKSEMPH
EKEELLNAAVYRVDALEAELITTKKALHEALIRQEELLGYIDRQKEAKCRRKKFCW*
>AT1G19650.2 | SEC14 cytosolic factor putative / phosphoglyceride transfer protein putative
MFWRSFICFITCSSIIRYEVEREHCLFHDFSSLCRFLFARKFDLGKAKLMWTNMIQWRRD
FGTDTILEDFEFPELDEVLRYYPQGYHGVDKEGRPVYIERLGKVDASKLMQVTTLERYLR
YHVKEFEKTITVKFPACCIAAKRHIDSSTTILDVQGLGLKNFTKTARDLIIQLQKIDSDN
YPETLHRMFIINAGSGFKLLWGTVKSFLDPKTVSKIHVLGNKYQNKLLEMIDASQLPDFF
GGTCTCADQGGCMRSDKGPWKDSEILKMGRSGGTFCRHAGAFLSSDSQISSSDKPTYSLK
VSDTSTAKSGSELEEMASPKTNTNNHVPKLTPVSEYANGNISPTVLSEYEECVPMVDKVV
DVAWQLQEMPNASEGPQYTSSLGKIGSVRHIWSWLTAFFISFFTLLASLALPQTKEHSQL
HSSSVRAELCDERIARESRPPSPPRSTITERVIISSVLSRLGDLEKQIENLHSRKSEMPH
EKEELLNAAVYRVDALEAELITTKKALHEALIRQEELLGYIDRQKEAKCRRKKFCW*
>AT1G06390.1 | GSK1 (GSK3/SHAGGY-LIKE PROTEIN KINASE 1) glycogen synthase kinase 3/ kinase
MASLPLGPQPHALAPPLQLHDGDALKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGK
NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDH
PNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFR
GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE
LIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNP
NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREP
NARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS*
>AT1G06390.1 | GSK1 (GSK3/SHAGGY-LIKE PROTEIN KINASE 1) glycogen synthase kinase 3/ kinase
MASLPLGPQPHALAPPLQLHDGDALKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGK
NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDH
PNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFR
GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE
LIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNP
NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREP
NARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS*
>AT1G06390.2 | GSK1 (GSK3/SHAGGY-LIKE PROTEIN KINASE 1) glycogen synthase kinase 3/ kinase
MASLPLGPQPHALAPPLQLHDGDALKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGK
NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDH
PNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFR
GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE
LIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNP
NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREP
NARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS*
>AT1G06390.2 | GSK1 (GSK3/SHAGGY-LIKE PROTEIN KINASE 1) glycogen synthase kinase 3/ kinase
MASLPLGPQPHALAPPLQLHDGDALKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGK
NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDH
PNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFR
GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE
LIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNP
NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREP
NARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS*
>AT5G35530.1 | 40S ribosomal protein S3 (RPS3C)
MATQISKKRKFVADGVFYAELNEVLTRELAEDGYSGVEVRVTPMRTEIIIRATRTQNVLG
EKGRRIRELTSLVQKRFKFPQDSVELYAEKVANRGLCAIAQAESLRYKLLGGLAVRRACY
GVLRFVMESGAKGCEVIVSGKLRAARAKSMKFKDGYMVSSGQPTKEYIDAAVRHVLLRQG
VLGLKVKIMLDWDPKGKQGPMTPLPDVVIIHTPKEDDVYIAPAQVVTQAAFVPEAPLTTT
DYPAMPVA*
>AT5G12020.1 | HSP176II (176 KDA CLASS II HEAT SHOCK PROTEIN)
MDLGRFPIISILEDMLEVPEDHNNEKTRNNPSRVYMRDAKAMAATPADVIEHPNAYAFVV
DMPGIKGDEIKVQVENDNVLVVSGERQRENKENEGVKYVRMERRMGKFMRKFQLPENADL
DKISAVCHDGVLKVTVQKLPPPEPKKPKTIQVQVA*
>AT1G12050.1 | fumarylacetoacetase putative
MALLKSFIDVGSDSHFPIQNLPYGVFKPESNSTPRPAVAIGDLVLDLSAISEAGLFDGLI
LKDADCFLQPNLNKFLAMGRPAWKEARSTLQRILSSNEPILRDNDVLRRKSFHQMSKVEM
IVPMVIGDYTDFFASMHHAKNCGLMFRGPENAINPNWFRLPIAYHGRASSIVISGTDIIR
PRGQGHPQGNSEPYFGPSKKLDFELEMAAVVGPGNELGKPIDVNNAADHIFGLLLMNDWS
ARDIQAWEYVPLGPFLGKSFGTTISPWIVTLDALEPFGCQAPKQDPPPLPYLAEKESVNY
DISLEVQLKPSGRDDSCVITKSNFQNLYWTITQQLAHHTVNGCNLRPGDLLGTGTISGPE
PDSYGCLLELTWNGQKPLSLNGTTQTFLEDGDQVTFSGVCKGDGYNVGFGTCTGKIVPSP
P*
>AT3G18940.1 | clast3-related
MEFVVEEGKLVNEDCSTLVLPALSIGNVGQLAVDLLVSSTGAERVGYLDDPNLLPCVGND
AYGPLPCGEIALPLEVYESSSIATTLAQQRSPVAKGMMIKFAENIANFAASSGKKHIIVL
SSLDFQRLHNLDMSRGPQVYYLSNAESDGRDDHCERLGFGRLHEYDSEGRCWKYLSSVFE
KNSVEELALPSEDELEDIDYYPSLPFAALFSAFKARGLKMTCLLCYCSEGDNIPEAFLLA
EASSKLMGLTPDKFHGEEGGKWQIPYSWKSMYGAPPDMSMF*
>AT2G37550.1 | AGD7 ARF GTPase activator/ DNA binding / zinc ion binding
MAAARRLRTLQSQPENKVCVDCSQKNPQWASISYGIFMCLECSGKHRGLGVHISFVRSVT
MDSWSEIQIKKMDAGGNERLNNFLAQYGISKETDIISKYNSNAASVYRDRIQALAEGRQW
RDPPIVKESVGGGLMNKKPPLSQGGGRDSGNGGWDNWDNDDSFRSTDMRRNQSAGDFRSS
GGRGAPAKSKSSEDIYSRSQLEASAANKESFFAKRMAENESKPEGLPPSQGGKYVGFGSS
PGPAPRSNQQSGGGDVFSVMSEGFGRLSLVAASAANVVQTGTMEFTSKVKEGGLDQTVSE
TVNVVASKTTEIGQRTWGIMKGVMAIASQKVEEFTKEEASTWNQQNKTEGNGYYQNSGIG
NKTANSSFGGSQSSSSGHNNSYRNSNSWDDWGEENNSKKEAAPKVSTSNDDDDGGWAGWD
DNDAKDDDFYYQPASDKKSVGHNGKSDTAWTGGGFL*
>AT2G37550.1 | AGD7 ARF GTPase activator/ DNA binding / zinc ion binding
MAAARRLRTLQSQPENKVCVDCSQKNPQWASISYGIFMCLECSGKHRGLGVHISFVRSVT
MDSWSEIQIKKMDAGGNERLNNFLAQYGISKETDIISKYNSNAASVYRDRIQALAEGRQW
RDPPIVKESVGGGLMNKKPPLSQGGGRDSGNGGWDNWDNDDSFRSTDMRRNQSAGDFRSS
GGRGAPAKSKSSEDIYSRSQLEASAANKESFFAKRMAENESKPEGLPPSQGGKYVGFGSS
PGPAPRSNQQSGGGDVFSVMSEGFGRLSLVAASAANVVQTGTMEFTSKVKEGGLDQTVSE
TVNVVASKTTEIGQRTWGIMKGVMAIASQKVEEFTKEEASTWNQQNKTEGNGYYQNSGIG
NKTANSSFGGSQSSSSGHNNSYRNSNSWDDWGEENNSKKEAAPKVSTSNDDDDGGWAGWD
DNDAKDDDFYYQPASDKKSVGHNGKSDTAWTGGGFL*
>AT2G37550.2 | AGD7 ARF GTPase activator/ DNA binding / zinc ion binding
MAAARRLRTLQSQPENKVCVDCSQKNPQWASISYGIFMCLECSGKHRGLGVHISFVRSVT
MDSWSEIQIKKMDAGGNERLNNFLAQYGISKETDIISKYNSNAASVYRDRIQALAEGRQW
RDPPIVKESVGGGLMNKKPPLSQGGGRDSGNGGWDNWDNDDSFRSTDMRRNQSAGDFRSS
GGRGAPAKSKSSEDIYSRSQLEASAANKESFFAKRMAENESKPEGLPPSQGGKYVGFGSS
PGPAPRSNQQSGGGDVFSVMSEGFGRLSLVAASAANVVQTGTMEFTSKVKEGGLDQTVSE
TVNVVASKTTEIGQRTWGIMKGVMAIASQKVEEFTKEEASTWNQQNKTEGNGYYQNSGIG
NKTANSSFGGSQSSSSGHNNSYRNSNSWDDWGEENNSKKEAAPKVSTSNDDDDGGWAGWD
DNDAKDDDFYYQPASDKKSVGHNGKSDTAWTGGGFL*
>AT2G37550.2 | AGD7 ARF GTPase activator/ DNA binding / zinc ion binding
MAAARRLRTLQSQPENKVCVDCSQKNPQWASISYGIFMCLECSGKHRGLGVHISFVRSVT
MDSWSEIQIKKMDAGGNERLNNFLAQYGISKETDIISKYNSNAASVYRDRIQALAEGRQW
RDPPIVKESVGGGLMNKKPPLSQGGGRDSGNGGWDNWDNDDSFRSTDMRRNQSAGDFRSS
GGRGAPAKSKSSEDIYSRSQLEASAANKESFFAKRMAENESKPEGLPPSQGGKYVGFGSS
PGPAPRSNQQSGGGDVFSVMSEGFGRLSLVAASAANVVQTGTMEFTSKVKEGGLDQTVSE
TVNVVASKTTEIGQRTWGIMKGVMAIASQKVEEFTKEEASTWNQQNKTEGNGYYQNSGIG
NKTANSSFGGSQSSSSGHNNSYRNSNSWDDWGEENNSKKEAAPKVSTSNDDDDGGWAGWD
DNDAKDDDFYYQPASDKKSVGHNGKSDTAWTGGGFL*
>AT2G29500.1 | 176 kDa class I small heat shock protein (HSP176B-CI)
MSMIPSFFNNNRRSNIFDPFSLDVWDPFKELTSSSLSRENSAIVNARVDWRETPEAHVFK
ADLPGLKKEEVKVEIEEDSVLKISGERHVEKEDKNDTWHRVERSSGQFTRRFRLPENVKM
DQVKAAMENGVLTVTVPKAETKKADVKSIQISG*
>AT1G71697.1 | ATCK1 (CHOLINE KINASE 1) choline kinase
MAIKTKTSLIPSCSSPEDLKRVLQTLGSSWGDVVEDLERLEVVPLKGAMTNEVYQINWPT
LNGEDVHRKVLVRIYGDGVDLFFNRGDEIKTFECMSHHGYGPKLLGRFSDGRLEEFIHAR
TLSADDLRVAETSDFIAAKLREFHKLDMPGPKNVLLWERLRTWLKEAKNLASPIEMDKYR
LEGLENEINLLEERLTRDDQEIGFCHNDLQYGNVMIDEVTNAITIIDYEYSSFNPIAYDI
ANHFCEMAANYHSDTPHVLDYTLYPGEGERRRFISTYLGSTGNATSDKEVERLLKDAESY
TLANHIFWGLWGIISGHVNKIEFDYMEYARQRFEQYWLRKPLLLEG*
>AT1G74320.1 | choline kinase putative
MTMGGTEKNVENKQYRLPREVKEALQAIASEWEDVIDSKALQVIPLKGAMTNEVFQIKWP
TREKGPSRKVLVRIYGEGVEIFFDREDEIRTFEFMSKHGHGPLLLGRFGNGRIEEFLHAR
TLSACDLRDPEISGRIATRMKEFHGLEMPGAKKALLWDRLRNWLTACKRLASPEEAKSFR
LDVMEMEINMLEKSLFDNDENIGFCHNDLQYGNIMMDEETKAITIIDYEYSCYNPVAYDI
ANHFCEMAADYHTETPHIMDYSKYPGVEERQRFLKTYMSYSDEKPSDTMVKKLLEDVEKY
TLASHLIWGLWGIISEHVNEIDFDYMEYARQRFEQYWLTKPRLLAASEHK*
>AT4G09760.3 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIVSLLLITTNLLNIFSFF
QNGGKKFKTHFYDTI*
>AT4G09760.3 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIVSLLLITTNLLNIFSFF
QNGGKKFKTHFYDTI*
>AT4G09760.3 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIVSLLLITTNLLNIFSFF
QNGGKKFKTHFYDTI*
>AT4G09760.2 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIDYEYASYNPIAYDIANH
FCEMAADYHSNTPHILDYTLYPGEEERRRFICNYLTSSGEEAREEDIEQLLDDIEKYTLA
SHLFWGLWGIISGYVNKIEFDYIEYSRQRFKQYWLRKPKLLSFFPS*
>AT4G09760.2 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIDYEYASYNPIAYDIANH
FCEMAADYHSNTPHILDYTLYPGEEERRRFICNYLTSSGEEAREEDIEQLLDDIEKYTLA
SHLFWGLWGIISGYVNKIEFDYIEYSRQRFKQYWLRKPKLLSFFPS*
>AT4G09760.2 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIDYEYASYNPIAYDIANH
FCEMAADYHSNTPHILDYTLYPGEEERRRFICNYLTSSGEEAREEDIEQLLDDIEKYTLA
SHLFWGLWGIISGYVNKIEFDYIEYSRQRFKQYWLRKPKLLSFFPS*
>AT4G09760.1 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIDYEYASYNPIAYDIANH
FCEMAADYHSNTPHILDYTLYPGEEERRRFICNYLTSSGEEAREEDIEQLLDDIEKYTLA
SHLFWGLWGIISGYVNKIEFDYIEYSRQRFKQYWLRKPKLLSFFPS*
>AT4G09760.1 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIDYEYASYNPIAYDIANH
FCEMAADYHSNTPHILDYTLYPGEEERRRFICNYLTSSGEEAREEDIEQLLDDIEKYTLA
SHLFWGLWGIISGYVNKIEFDYIEYSRQRFKQYWLRKPKLLSFFPS*
>AT4G09760.1 | choline kinase putative
MAVGIFGLIPSSSPDELRKILQALSTKWGDVVEDFESLEVKPMKGAMTNEVFMVSWPRKE
TNLRCRKLLVRVYGEGVELFFNRDDEIRTFEYVARHGHGPTLLGRFAGGRVEEFIHARTL
SATDLRDPNISALVASKLRRFHSIHIPGDRIMLIWDRMRTWVGQAKNLCSNEHSTEFGLD
DIEDEINLLEQEVNNEQEIGFCHNDLQYGNIMIDEETNAITIIDYEYASYNPIAYDIANH
FCEMAADYHSNTPHILDYTLYPGEEERRRFICNYLTSSGEEAREEDIEQLLDDIEKYTLA
SHLFWGLWGIISGYVNKIEFDYIEYSRQRFKQYWLRKPKLLSFFPS*